Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
Ariizumi Y, Hanai N, Asakage T, Seto A, Tomioka T, Miyabe J, Kessoku H, Mukaigawa T, Omura G, Teshima M, Nishikawa D, Saito Y, Asada Y, Fujisawa T, Makino T, Nishino H, Sano D, Nakahira M, Tokashiki K, Uemura H, Ueda T, Sakai A, Masuda M, Tsujikawa T, Hiei Y, Nishio N, Matsui H, Kiyota N, Homma A. Ariizumi Y, et al. Among authors: fujisawa t. Head Neck. 2024 Feb;46(2):269-281. doi: 10.1002/hed.27572. Epub 2023 Nov 13. Head Neck. 2024. PMID: 37955187
Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.
Sano D, Fujisawa T, Tokuhisa M, Shimizu M, Sakagami T, Hatano T, Nishimura G, Ichikawa Y, Iwai H, Oridate N. Sano D, et al. Among authors: fujisawa t. Anticancer Res. 2019 Dec;39(12):6819-6827. doi: 10.21873/anticanres.13898. Anticancer Res. 2019. PMID: 31810948
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y, Hayashi R, Iida Y, Mizumachi T, Fujii T, Matsumoto F, Beppu T, Yoshida M, Shinomiya H, Kamiyama R, Kitano M, Yokoshima K, Fujimoto Y, Hama T, Yamashita T, Okami K, Miura K, Fujisawa T, Sano D, Kato H, Minami S, Sugasawa M, Masuda M, Ota I, Iwae S, Kawata R, Monden N, Imai T, Asakage T, Okada M, Yoshikawa T, Tanioka K, Kitayama M, Doi M, Fujii S, Fujii M, Oridate N, Nakamizo M, Yoshimoto S, Homma A, Nibu KI, Yane K. Saito Y, et al. Among authors: fujisawa t. Cancer. 2020 Sep 15;126(18):4177-4187. doi: 10.1002/cncr.33062. Epub 2020 Jul 10. Cancer. 2020. PMID: 32648953 Free article.
Combination of Performance Status and Lymphocyte-monocyte Ratio as a Novel Prognostic Marker for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
Aoyama J, Kuwahara T, Sano D, Fujisawa T, Tokuhisa M, Shimizu M, Sakagami T, Ichikawa Y, Iwai H, Oridate N. Aoyama J, et al. Among authors: fujisawa t. Cancer Diagn Progn. 2021 Jul 3;1(4):353-361. doi: 10.21873/cdp.10047. eCollection 2021 Sep-Oct. Cancer Diagn Progn. 2021. PMID: 35403150 Free PMC article.
Neurofibromatosis type 2 associated with cranial nerve schwannomas.
Minamino M, Iwai H, Yano J, Fujisawa T, Yamashita T. Minamino M, et al. Among authors: fujisawa t. Otolaryngol Head Neck Surg. 2001 May;124(5):581-3. doi: 10.1067/mhn.2001.115170. Otolaryngol Head Neck Surg. 2001. PMID: 11337669 No abstract available.
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Ikoma T, Matsumoto T, Boku S, Motoki Y, Kinoshita H, Kosaka H, Kaibori M, Inoue K, Sekimoto M, Fujisawa T, Iwai H, Naganuma M, Tanizaki H, Hisamatsu Y, Okada H, Kurata T. Ikoma T, et al. Among authors: fujisawa t. Cancer Immunol Immunother. 2024 May 11;73(7):126. doi: 10.1007/s00262-024-03707-4. Cancer Immunol Immunother. 2024. PMID: 38733406 Free PMC article.
2,175 results